I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

In recent years, chronic kidney disease (CKD) has become a leading public health concern in China and other countries,\[[@ref1]\] as it is associated with increased morbidity, mortality, and financial costs. The overall prevalence of CKD in China ranges from 10.8% to 13%.\[[@ref2]\] Despite numerous studies, there are no early diagnostic markers for CKD.\[[@ref3]\] The renal biopsy is still the golden diagnostic criterion for nephropathy.

The first renal biopsies in China were performed in the 1980s. Now, they are performed widely in tertiary hospitals.\[[@ref4][@ref5]\] Some hospitals have reported on the spectrum of pathological types seen in renal biopsies, but the overall situation regarding the common types of glomerular disease in China remains unclear. The distribution of the spectrum of glomerular disease varies temporally and geographically and in different ethnic groups.\[[@ref6]\] Few studies have systematically investigated the spectrum of primary glomerulonephritis (PGN) and secondary glomerulonephritis (SGN) in China when stratified by geographic region and time period. Therefore, this study was focused on the detection rate of different types of glomerulonephritis and aimed to assess the national profile of the common types of PGN and SGN in China.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

This systematic review followed the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions,\[[@ref7]\] and the report complies with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.\[[@ref8]\] The protocol and registration information are available at [http://www.crd.york.ac.uk/PROSPERO/(CRD 42017082724)](http://www.crd.york.ac.uk/PROSPERO/(CRD42017082724)).

Search strategy {#sec2-1}
---------------

We performed a systematic electronic search of the PubMed, Embase, Cochrane Library, SinoMed (Chinese Biomedical Literature Database), Chinese National Knowledge Infrastructure (CNKI), VIP, and Wanfang databases from their inceptions through September 2017.

All articles written in either Chinese or English containing any word regarding pathological types of renal biopsy were identified; the following words in combinations are as keywords: "renal biopsy," "kidney pathological diagnosis," and "spectrum of pathological types." After completing the electronic database search, we performed a manual search of professional journals and thesis.

Inclusion and exclusion criteria {#sec2-2}
--------------------------------

Studies that met the following inclusion criteria were included in the review: (1) renal biopsy performed in a hospital located in China; (2) more than 1000 cases were reported in the study; (3) the total cases of renal biopsy, PGN, and SGN were reported or could be calculated; and (4) detection rates of various types of glomerular diseases were reported or could be calculated.

Studies were rejected for the following reasons: (1) inclusion of data from other countries or regions and (2) limits placed on age or gender.

Record selection and data extraction {#sec2-3}
------------------------------------

Two authors (Yang Y and Zhang Z) performed the initial search independently, deleted duplicate records, screened the titles and abstracts for relevance, and identified records as included, excluded, or uncertain. In the case of uncertainty, a third researcher (Zhuo L) was responsible for examining the data and discussing the findings with the other two. Studies were included only when all three researchers reached a consensus.

Data were extracted by Yang Y and confirmed independently by two other authors (Zhang Z and Zhuo L). We also sought supplementary appendices of the included studies or contacted the corresponding authors to verify the extracted data and request any missing data. Discrepancies were resolved by discussion with the coauthors. The predefined outcomes were the detection rates of the top five types of PGN and top four types of SGN and their proportion trends.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Basic information regarding the studies included {#sec2-4}
------------------------------------------------

The electronic and manual searches identified 2027 potentially relevant papers. After browsing the titles and abstracts, we selected 421 papers. After reading the entire texts of these 421 papers, we excluded 398 papers and included 23 papers,\[[@ref4][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27][@ref28][@ref29][@ref30]\] with a total of 176,355 patients from 15 different provinces/cities in China. According to the geographical and administrative divisions, we divide our country into five regions: north, east, south, west, and central China, at least two studies were included in each region. In east and south China, the economically developed regions, more than 130,000 cases were enrolled, and even in west China, there are still more than 10,000 cases. The process of paper inclusion is shown in Supplementary Figure 1, and the detailed information on the studies is summarized in [Table 1](#T1){ref-type="table"}.

###### 

Characteristics of studies included in the systematic review

  Study                        Year   Region          Province    Biopsies (*N*)   PGN (*N*)   SGN (*N*)   Patients' gender (male/female)   Patients' age (years)
  ---------------------------- ------ --------------- ----------- ---------------- ----------- ----------- -------------------------------- -------------------------------------------
  Chen *et al*.\[[@ref5]\]\*   2000   East China      Jiangsu     10,594           7059        2283        5654/4348^†^                     31.4 ± 13.0^†^
  Li and Ye\[[@ref9]\]         2003   East China      Zhejiang    1171             1009        124         539/632                          8--79
  Li and Liu\[[@ref10]\]\*     2004   East China      Jiangsu     13,519           9278        3359        7752/5767                        32.7 ± 12.2
  Wang *et al*.\[[@ref11]\]    2005   East China      Jiangxi     1602             1205        320         952/650                          29.6 (6--68)
  Du *et al*.\[[@ref12]\]      2006   West China      Shanxi      1542             1070        414         937/604                          43.54 ± 15.3
  Li *et al*.\[[@ref13]\]      2006   North China     Liaoning    1295             990         246         730/565                          33.62 ± 8.53
  Liu *et al*.\[[@ref14]\]     2009   South China     Guangdong   1245             1031        170         506/739                          9--73
  Xu *et al*.\[[@ref15]\]      2009   South China     Guangdong   1627             1214        103         811/816                          30.7 ± 15.1
  Liao\[[@ref16]\]             2010   South China     Guangxi     3035             2194        760         1539/1496                        34.10 ± 14.78
  Zhang *et al*.\[[@ref17]\]   2010   Central China   Henan       1200             870         273         690/510                          35.5 ± 15.3
  Li *et al*.\[[@ref18]\]      2011   North China     Liaoning    1042             840         185         485/557                          35.83 ± 15.03
  Du\[[@ref19]\]               2011   West China      Xinjiang    1148             874         149         602/546                          34.06 ± 11.84
  Shang and Yin\[[@ref20]\]    2011   West China      Shanxi      5000             3870        972         3306/1694                        35.5 ± 11.4
  Shi\[[@ref21]\]              2012   East China      Fujian      36,379           13,825      6953        18,553/17,826                    30.53 ± 15.07
  Wu *et al*.\[[@ref22]\]      2013   Central China   Henan       6995             4638        2191        3636/3359                        Male: 33.64 ± 17.75 Female: 35.36 ± 15.46
  Luo\[[@ref23]\]              2013   West China      Xinjiang    1224             1000        149         661/563                          4--82
  Wei *et al*.\[[@ref24]\]     2013   East China      Shandong    1071             795         258         538/533                          7--81
  Liu and Zhang\[[@ref25]\]    2014   West China      Yunnan      1594             893         550         894/700                          45.54 ± 10.44
  Zhang *et al*.\[[@ref4]\]    2014   North China     Beijing     11,608           8209        2406        6646/4972                        35 (3--85)
  Sun *et al*.\[[@ref26]\]     2014   West China      Shanxi      1363             1119        209         712/651                          37.0 ± 7.8
  Yang *et al*.\[[@ref27]\]    2015   North China     Jilin       4382             2781        1341        2434/1948                        6--82
  Li *et al*.\[[@ref28]\]      2016   East China      Anhui       1217             1022        186         666/551                          34.5 ± 15.8
  Xu *et al*.\[[@ref29]\]      2016   South China     Guangdong   71,151           54,743      15,883      35,641/35,510                    37.3 ± 15.9
  Wang *et al*.\[[@ref30]\]    2017   East China      Shandong    5935             --          1038        525/513^‡^                       38.05 ± 17.05^‡^

\*Two articles were performed with the same team at different periods. In our study, Chen's article was only used to analyze the trend of primary glomerulus nephritis; ^†^Data from 10,002 nontransplant patients; ^‡^Data from 1038 secondary glomerulus nephritis patients; PGN: Primary glomerulonephritis; SGN: Secondary glomerulonephritis; --: Not applicable.

###### 

Flow diagram.

###### 

Click here for additional data file.

Detection rate of the main primary glomerulonephritis in China {#sec2-5}
--------------------------------------------------------------

The detection rate of PGN to renal biopsy patients in China was based on 22 studies\[[@ref4][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27][@ref28][@ref29]\] involving 170,420 cases. The detection rate of PGN was 0.740 (126,031 cases).

IgA nephropathy (IgAN, 24.3%), mesangial proliferative glomerulonephritis (MsPGN, 10.5%), membranous nephropathy (MN, 12.6%), minimal change disease (MCD, 9.8%), and focal segmental glomerulosclerosis (FSGS, 4.6%) were the most common pathological types. Pathological data were also analyzed with different regions of China \[[Table 2](#T2){ref-type="table"}\].

###### 

Detection rate of PGN in China, *n* (%)

  Region           *N*       IgAN            MsPGN           MN              MCD             FSGS
  ---------------- --------- --------------- --------------- --------------- --------------- ------------
  North China      18,337    5820 (31.7)     2446 (13.3)     2055 (11.2)     975 (5.3)       836 (4.6)
  East China       54,959    10,326 (18.8)   7527 (13.7)     2657 (4.8)      1376 (2.5)      1721 (3.1)
  South China      77,058    20,898 (27.1)   4271 (5.5)      15,143 (19.7)   12,288 (15.9)   4287 (5.6)
  Central China    8195      2048 (25.0)     396 (4.8)       744 (9.1)       1580 (19.3)     414 (5.1)
  West China       11,871    2256 (19.0)     3185 (26.8)     951 (8.0)       531 (4.5)       519 (4.4)
                                                                                             
  Total in China   170,420   41,348 (24.3)   17,825 (10.5)   21,550 (12.6)   16,750 (9.8)    7777 (4.6)

IgAN: IgA nephropathy; MsPGN: Mesangial proliferative glomerulonephritis; MN: Membranous nephropathy; MCD: Minimal change disease; FSGS: Focal segmental glomerulosclerosis; PGN: Primary glomerulonephritis.

Detection rate of the main secondary glomerulonephritis in China {#sec2-6}
----------------------------------------------------------------

The detection rate of SGN to renal biopsy patients in China was based on 23 studies\[[@ref4][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27][@ref28][@ref29][@ref30]\] involving 176,355 cases. The detection rate of SGN was 0.221 (38,979 cases).

Lupus nephritis (LN, 8.6%), Henoch-Schönlein purpura glomerulonephritis (HSP-GN, 4.1%), hepatitis B virus-associated nephritis (HBV-GN, 2.6%), and diabetic nephropathy (DN, 1.6%) were the most common pathological types. Pathological data were also analyzed with different regions of China \[[Table 3](#T3){ref-type="table"}\].

###### 

Detection rate of SGN in China, *n* (%)

  Region           *N*       LN             HSP-GN       HBV-GN       DN
  ---------------- --------- -------------- ------------ ------------ ------------
  North China      18,337    1188 (6.5)     1025 (5.6)   631 (3.4)    449 (2.4)
  East China       60,894    5397 (8.9)     2668 (4.4)   2216 (3.6)   731 (1.2)
  South China      77,058    6674 (8.7)     2377 (3.1)   1108 (1.4)   1283 (1.7)
  Central China    8195      868 (10.6)     508 (6.2)    326 (4.0)    113 (1.4)
  West China       11,871    967 (8.1)      604 (5.1)    245 (2.1)    211 (1.8)
                                                                      
  Total in China   176,355   15,094 (8.6)   7182 (4.1)   4526 (2.6)   2787 (1.6)

LN: Lupus nephritis; HSP-GN: Henoch--Schönlein purpura glomerulonephritis; HBV-GN: Hepatitis B virus-associated glomerulonephritis; DN: Diabetic nephropathy; SGN: Secondary glomerulonephritis.

Trends in frequency of the most common glomerulopathies in China {#sec2-7}
----------------------------------------------------------------

To observe the changing trend of disease spectrum of renal biopsy, we set three periods: before 2000 (period 1), 2001--2010 (period 2), and after 2010 (period 3).

The trends of PGN proportion were based on 16 studies\[[@ref4][@ref5][@ref9][@ref12][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref21][@ref22][@ref23][@ref25][@ref26][@ref28]\] involving 55,014 cases. The proportion of IgAN, MsPGN, and FSGS tended to drop, that is, 36.7% versus 28.3%, 33.7% versus 14.1%, and 7.0% versus 2.1% during period 1 and period 3, respectively \[[Figure 1](#F1){ref-type="fig"}\]. The proportion of MN and MCD tended to rise, that is, 8.2% versus 16.3% and 1.4% versus 16.4% during period 1 and period 3, respectively \[[Figure 1](#F1){ref-type="fig"}\].

![Trend of PGN in China. Trends of proportion (%) of PGN in China. PGN: Proliferative glomerulonephritis; IgAN: IgA nephropathy; MsPGN: Mesangial PGN; MN: Membranous nephropathy; MCD: Minimal change disease; FSGS: Focal segmental glomerulosclerosis.](CMJ-131-731-g001){#F1}

The trends of SGN proportion were based on 16 studies\[[@ref4][@ref5][@ref9][@ref12][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref22][@ref23][@ref25][@ref26][@ref28][@ref30]\] involving 10,243 cases. The proportion of LN tended to drop, that is, 53.1% versus 23.9% during period 1 and period 3 \[[Figure 2](#F2){ref-type="fig"}\]. The proportion of HBV-GN and DN tended to rise, that is, 2.7% versus 12.4% and 6.2% versus 18.8% during period 1 and period 3, respectively \[[Figure 2](#F2){ref-type="fig"}\].

![Trend of SGN in China. Trends of proportion (%) of SGN in China. SGN: Secondary glomerulonephritis; LN: Lupus nephritis; HSP-GN: Henoch-Schönlein purpura glomerulonephritis; HBV-GN: Hepatitis B virus-associated nephritis; DN: Diabetic nephropathy.](CMJ-131-731-g002){#F2}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

This systematic review identified 23 studies involving more than 170,000 patients from 15 provinces/cities in China. The detection rates of PGN and SGN in all renal biopsies were 0.740 and 0.221, respectively. PGN is still the leading kidney disease in patients undergoing renal biopsies in China, although the detection rate of PGN has decreased gradually, while the incidence of SGN has increased. The top five types of PGN were IgAN, MsPGN, MN, MCD, and FSGS and the top four types of SGN were LN, HSP-GN, HBV-GN, and DN.

IgAN may be the most common type of PGN worldwide. While the detection rate in Africa was \<5%,\[[@ref31]\] it was 17.8--22.0% in America,\[[@ref32][@ref33]\] 26--37% in Europe,\[[@ref34][@ref35]\] and up to 30--40% in Asia.\[[@ref36][@ref37]\] In countries in East Asia, the detection rate of MsPGN in a broad sense (IgAN and non-IgA MsPGN) can exceed 50%.\[[@ref36][@ref37]\] Obviously, ethnic and genetic factors play important roles. The prevalence of IgAN and MsPGN has decreased in the recent decades. The main reasons for this may be that other types of PGN, such as MN, have increased and PGN is being diagnosed more accurately, while MsPGN tended to be misdiagnosed in the past.

MN was the leading cause of nephrotic syndrome in middle age, whereas MCD was the most common histological diagnosis among younger patients. The detection rate of MN was about 20% in Brazil\[[@ref38]\] and Italy\[[@ref35]\] and 10% in the USA.\[[@ref32]\] In Asia, MN was not as common in the past, but its incidence is increasing.\[[@ref6][@ref29][@ref36]\] The presence of unidentified environmental factors, such as PM2.5, may increase the risk of MN.\[[@ref29]\]

In recent years, the incidence of FSGS has tended to increase in the USA\[[@ref39]\] and Brazil,\[[@ref40]\] but it dropped in our study. The area-varying distribution of FSGS might be related to race and environmental factors.\[[@ref39]\]

LN is the most common SGN worldwide, comprising 45.5--66.2% of all SGN.\[[@ref31][@ref32][@ref34][@ref38]\] Our data showed a nonsignificant tendency for a decrease in the detection rate by decade. With advances in clinical medicine and technology, more autoimmune diseases are being identified and diagnosed, which may explain the trend in LN.

The prevalence of DN increased significantly after 2010. It is SGN caused by diabetes mellitus and is one of the most common diabetic complications. The prevalence of type 2 diabetes mellitus has increased rapidly in recent decades, and it has become a global public health problem. Diabetes is the leading cause of CKD in developed countries, whereas glomerulonephritis has been identified as the predominant cause of CKD in developing countries. Zhang *et al*\[[@ref41]\] was the first to report that CKD was more frequently associated with diabetes than glomerulonephritis in China, in both the general population and a hospitalized urban population. DN will likely play a more important role in the spectrum of SGN in China in the coming decades.

This present study also had limitations. Due to the high heterogeneity, the existing data are not suitable for meta-analysis. The inter-regional and regional differences and heterogeneity may be related to many factors. The reasons for the differences between regions are complex and may involve nationality, population mobility, economic conditions, education, environment, diet, and other factors. Second, there are significant differences in renal biopsy indications between regions; in some areas, it is considered only in patients with nephrotic syndrome and normal renal function. This will undoubtedly lead to heterogeneity in the spectrum of renal biopsy between hospitals. Third, the production and staining process of kidney sections and the diagnostic accuracy of pathologist differ across regions. In some underdeveloped areas, this is still a long way to go. Clinicians and pathologists in different provinces and cities require standardized training and the uniform guidelines are needed urgently.

In summary, although decreasing gradually, IgAN and MsPGN are still the most common types of PGN in patients undergoing renal biopsies in China, whereas LN is still the top SGN. The detection rates of MN, MCD, and DN are tending to increase, while that of FSGS is dropping. Differences between regions are related to various factors. Unified standards for assessing renal biopsies are urgently needed.

*Supplementary information is linked to the online version of the paper on the Chinese Medical Journal website*.
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